Functional Insights At Any Stage Of The Adoptive Cell Therapy Manufacturing Process

Bruker IsoCode® Single-Cell Secretome platform and Workflow can provide valuable functional insights to your organization at any stage of the Adoptive cell therapy (ACT) manufacturing process. This platform simultaneously measures the functional secretion of 32+ cytokines from single-cells, researchers can obtain critical insights into biomarkers that are inaccessible using other proteomic platforms.

The following topics have been outlined to assist in deciding to use IsoCode^®:

• The importance of polyfunctional cells in adoptive cell therapy
• The Bruker IsoCode^® Single-Cell Secretome platform and Workflow
• Pre-clinical product characterization for early insights into efficacy and function
• Tracking cellular functionality to optimize manufacturing
• Discovering predictive clinical biomarkers that correlate with clinical outcomes